LOUISVILLE, Colo., June 5, 2023 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc replacement, today announced it has completed enrollment in its first-ever IDE clinical trial. The 1-Level Synergy Disc IDE…
Related Articles
Mosaic Biosciences Expands Its Leading Drug Discovery and Development Expertise
BOULDER, Colo.–(BUSINESS WIRE)–Mosaic Biosciences, a drug discovery organization that provides comprehensive protein and antibody therapeutics research expertise to its biotech, biopharma, and academic partners, today announced two strategic leadership additions to its team: Malavi Madireddi, […]
CU Anschutz Steps Back Into the Spotlight With New Marketing Campaign
On Sunday, Feb. 9, during the Super Bowl, CU Anschutz will return to televisions and airwaves across the Denver metro area with a vibrant new marketing campaign. Titled Where Dreams Live, the campaign presents an […]
Biodesix Announces Proposed Public Offering of Common Stock
BOULDER, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it has commenced an underwritten public offering of $30 million of shares […]
